What is iGeneScreenTM
Safe. Non-Invasive. 99% Accurate.
iGeneScreenTM is a safe, non invasive, highly accurate prenatal blood test that analyses cell-free fetal DNA in maternal blood to detect fetal trisomies. It involves taking a 10 ml sample of blood from the expectant mother as early as 10 weeks of pregnancy.
iGeneScreenTM has been validated prospectively on 11,105 cases, the largest prospective study for any non-invasive prenatal test to date.
The study showed iGeneScreenTM to be more than 99% accurate in detecting chromosomal abnormalities, in particular Down Syndrome and Edwards Syndrome.
The study was independently peer-reviewed and published in Prenatal Diagnosis, an internationally recognised publication, and the Official Journal of the International Society for Prenatal Diagnosis (ISPD).
iGeneScreenTM detects Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome) and Trisomy 13 (Patau syndrome) with more than 99% accuracy, compared with existing screening tests such as the nuchal translucency and first trimester screening test.
It is anticipated that the test will very significantly reduce the number of invasive diagnostic tests such as Amniocentesis and Chrorionic Villus Sampling, which carry a risk of miscarriage of about 1 in 100.